Sit to Stand Intervention for Allina Health Employees

Quality of Life Clinical Trial

Official title:

A Sit-to-Stand Intervention for Allina Health Employees: A Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02206113
• Other study ID #: 3989-1
• Status: Completed
• Phase: N/A
• First received: July 28, 2014
• Last updated: January 26, 2015
• Start date: May 2013
• Est. completion date: November 2013

Study information

• Verified date: January 2015
• Source: Allina Health System
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

A 16 week pilot study for Allina call center employees to look at the psychological outcomes and biological markers after an intervention of using a standing work station. There were two groups: group 1 received, and was instructed to use, the standing work station for all 16 weeks, group 2 was a wait-list control group and received, and was instructed to use, the standing work station for the second 8 weeks. Psychological outcomes were measured at weeks 0, 4, 8, 12, and 16. Biological markers were measured at weeks 0, 8, and 16.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 39
• Est. completion date: November 2013
• Est. primary completion date: November 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Allina Health Call Center Employee (75% or higher employee status)

• Aged 18 to 65 years

• Provide written informed consent

Exclusion Criteria:

• Unable to stand for 20 minutes continuously unaided

• Home based employees

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Quality of Life
• Stress

Intervention

Behavioral:
• Standing workstation

Locations

Country	Name	City	State
United States	Allina Health	Minneapolis	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Allina Health System

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in self-reported quality of life	Change in quality of life will be measured through the administration of the PROMIS-29 questionnaire.	Baseline, week 4, week 8, week 12, week 16	No
Secondary	Change in waist circumference	Waist circumference measured in inches	Baseline, Week 8, Week 16	No
Secondary	Change in number of minutes stood per day	Participants recorded their number of minutes stood at work daily from baseline through week 16.	Baseline, week 8, week 16	No
Secondary	Change in self-reported stress	Change in stress will be measured through the administration of the Perceived Stress Scale (PSS).	Baseline, week 4, week 8, week 12, week 16	No
Secondary	Change in health promotion and lifestyle choices	Change in health promotion and lifestyle choices will be measured through the administration of the Health Promoting Lifestyle Profile Questionnaire (HPLP-II).	Baseline, week 4, week 8, week 12, week 16	No
Secondary	Change in workplace productivity	Change in workplace productivity will be measured through the administration of Workplace Productivity and Activity Impairment (WPAI) questionnaire.	Baseline, week 4, week 8, week 12, week 16	No
Secondary	Change in self-reported physical activity levels	Change in self-reported physical activity levels will be measured through the administration of the International Physical Activity Questionnaire (IPAQ)	Baseline, week 4, week 8, week 12, week 16	No
Secondary	Change in Body Mass Index (BMI)	Change in an individual's BMI after being weighed at baseline, week 8, and week 16.	Baseline, Week 8, Week 16	No
Secondary	Change in body fat percentage	Change in body fat percentage as measured by a BodPod® Assessment.	Baseline, week 8, week 16	No
Secondary	Change in resting heart rate	Change in resting heart rate from baseline to week 16.	Baseline, week 8, week 16	No
Secondary	Change in blood pressure (systolic and diastolic)	Change in both systolic and diastolic blood pressure from baseline to week 16.	Baseline, week 8, week 16	No